Merindale is built on a simple idea: useful consulting starts with accuracy, respect for the people doing the work, and recommendations a research team can defend after we leave.
Work with the team, not around it.
Clinical research operations are rarely improved by an outside person arriving with a prewritten answer. The people closest to the study usually know where the friction lives; they may simply need time, structure, cross-functional visibility, or an experienced outside perspective to turn that knowledge into a workable change.
Merindale listens first. We review the evidence, understand how the current process developed, and work with the people who will have to run the new process after the engagement ends.
That is the standard we want clients to hold us to.
We will not stretch experience, capabilities, credentials, project results, or security controls to win work. If a question sits outside our expertise, we say so. If another type of advisor is a better fit, we say that too.
Operational problems are usually system problems before they are people problems. We look at timelines, workload, ownership, handoffs, source data, monitoring actions, and process design before concluding that an individual simply needs to “work harder.”
Recommendations are developed with the people who know the study and will own the change. We would rather build a simpler workflow the team trusts than a sophisticated model that survives only while a consultant is present.
Operational efficiency does not override participant rights, safety, informed consent, protocol requirements, or applicable research oversight. Changes should make compliant work easier to perform and easier to see.
We prefer to work with the least sensitive information needed for the scope and, where practical, inside client-approved systems. Sensitive or regulated information should only be accessed after the appropriate contractual and technical controls are established.
Potential conflicts that could reasonably affect an engagement should be disclosed. Recommendations should serve the agreed client objective, not a hidden technology sale, referral incentive, or pressure to expand scope unnecessarily.
Clear scope. Candid communication. A clean handback.
At the beginning: a shared understanding of the problem, the evidence we need, the people who should be involved, and what success would look like.
During the work: direct communication, visible decisions, respect for institutional processes, and no surprises about scope.
At the end: practical outputs with named ownership, measures, documentation, and a transition the internal team can sustain.
For the operating model behind this approach, see how Merindale works. For security and information boundaries, review our Data Handling & Security statement.
If you have a defined clinical trial site problem, we can start by deciding together whether Merindale is the right fit.